Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor. Download Section Flyer
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Advances in Antibody–Drug Conjugates (Deadline: 20 July 2026)
- G-Protein-Coupled Receptors as Therapeutic Targets for CNS Disorders (Deadline: 24 July 2026)
- Research Progress and Drug Intervention Strategies for Oral Health-Related Diseases (Deadline: 25 July 2026)
- Development of Antibacterial Drugs to Combat Drug-Resistant Bacteria: 2nd Edition (Deadline: 25 July 2026)
- Clinical Advances in the Neuropharmacological Treatment of Substance Use Disorders: 2nd Edition (Deadline: 25 July 2026)
- Emerging Therapies for Diabetes and Obesity (Deadline: 25 July 2026)
- Pharmacotherapy of Inflammatory Bowel Disease, 2nd Edition (Deadline: 25 July 2026)
- Advances in Perinatal Pharmacology (Deadline: 25 July 2026)
- Therapeutic Drug Monitoring and Adverse Drug Reactions: 3rd Edition (Deadline: 25 July 2026)
- Drug Target Exploration and Drug Design & Development Based on Small Molecule: 2nd Edition (Deadline: 25 July 2026)
- Therapeutic Potential of Cannabinoids and Their Receptors: 2nd Edition (Deadline: 25 July 2026)
- Aging-Related Musculoskeletal Disorders: Therapeutic Targets and Pharmacological Strategies (Deadline: 27 July 2026)
- Pharmacological Activities and Therapeutic Potential of Novel Drug Derivatives (Deadline: 31 July 2026)
- Pharmacology and Toxicology of Opioids, 2nd Edition (Deadline: 31 July 2026)
- The Regulatory Roles of the Gut Microbiota in Multisystem Diseases (Deadline: 31 July 2026)
- Advances in Targeted Therapy for Gastrointestinal Cancers (Deadline: 31 July 2026)
- Treating Cognitive Deficits in Neuropsychiatric and Neurodegenerative Disorders: Mechanisms, Targets, and Translational Advances (Deadline: 31 July 2026)
- New Advances and Treatment in Thrombosis and Endothelial Injury Syndromes (Deadline: 31 July 2026)
- Population Pharmacokinetics and Pharmacogenetics, 2nd Edition (Deadline: 10 August 2026)
- Application of Zebrafish Model in Pharmacology and Toxicology (Deadline: 15 August 2026)
- Innovative Approaches to GABAergic Drug Discovery: From Molecular Mechanisms to Advanced Therapeutics (Deadline: 25 August 2026)
- Chemotherapeutic and Targeted Drugs in Antitumor Therapy (Deadline: 25 August 2026)
- Drug Treatment for Epilepsy (Deadline: 25 August 2026)
- Perioperative Precision in Modern Anesthesia: Efficacy and Safety of Pharmacotherapy with Risk Modulation (Deadline: 25 August 2026)
- Innovative Tools for Drug Analysis and Therapeutic Drug Monitoring (TDM): 2nd Edition (Deadline: 25 August 2026)
- Immunotherapy as a Promising Therapeutic Paradigm for Cancers (Deadline: 25 August 2026)
- Innovative Drug Strategies in Chronic Disease Management: Addressing Non-Adherence and Improving Therapeutic Outcomes (Deadline: 27 August 2026)
- Drug Candidates for the Treatment of Oral Cancer and Oral Cancer Pain, 2nd Edition (Deadline: 27 August 2026)
- Vitamin D and Its Derivatives in Pharmacology: Mechanisms and Therapeutic Applications (Deadline: 27 August 2026)
- Applications of Pharmacogenomics in Precision Medicine (Deadline: 31 August 2026)
- Novel Vasoactive and Anti-Inflammatory Agents: From Mechanisms to Therapeutic Applications (Deadline: 31 August 2026)
- Contemporary Challenges and Solutions in Antimicrobial Use (Deadline: 31 August 2026)
- Advances in Neuropharmacology and Brain Injury Therapeutics (Deadline: 31 August 2026)
- Active Molecule Design Based on Conformational Pharmacology: Synthesis, NMR Spectroscopy, and Computational Modeling (Deadline: 31 August 2026)
- From Prion Molecular Mechanisms to Targeted Therapeutics: Informing the Broader Proteinopathy Paradigm (Deadline: 31 August 2026)
- Advances in Drug Treatment of Systemic Amyloidosis (Deadline: 31 August 2026)
- Pharmacogenomics and Pediatric Pharmacotherapy (Deadline: 10 September 2026)
- Multiomics Perspective in Pharmacogenomics (Deadline: 20 September 2026)
- Advances in Prostate Cancer Therapeutics (Deadline: 25 September 2026)
- Novel Anti-Obesity Pharmacotherapies (Deadline: 25 September 2026)
- Fluoroquinolones, 2nd Edition (Deadline: 25 September 2026)
- Ophthalmic Drugs and Pharmacology (Deadline: 25 September 2026)
- Pharmacokinetics and Pharmacometrics Driving Innovation (Deadline: 25 September 2026)
- Low-Dose Naltrexone for Chronic and Cancer Pain (Deadline: 25 September 2026)
- Drug Therapy for Autoimmune and Inflammatory Skin Conditions (Deadline: 25 September 2026)
- New Advances in Drug Associations, Complications and Clinical Research of Diabetes and Related Diseases (Deadline: 25 September 2026)
- Drug Treatment for Ophthalmic Diseases (Deadline: 25 September 2026)
- Impact of Drug Transporter Gene Variation on Pharmacokinetics and Clinical Outcomes in Chronic Disease Therapy (Deadline: 28 September 2026)
- Targeting Epigenetic Regulation for Cancer Therapy (Deadline: 30 September 2026)
- Membrane Receptors in Disease: Mechanisms and Targeted Therapeutic Strategies (Deadline: 30 September 2026)
- The Therapeutic Potential of Neurotrophin Signaling in Neurodegenerative Disorders (Deadline: 30 September 2026)
- Pain Management: Novel Biomarkers and Therapeutic Targets (Deadline: 30 September 2026)
- Pharmacological Therapies and Biomarkers for Diseases in Correlation with Age Groups of Patients (Deadline: 30 September 2026)
- Novel Neuroprotective Agents and Therapeutics (Deadline: 30 September 2026)
- Spectroscopic and Thermodynamic Insights into Drug-Protein Interactions (Deadline: 30 September 2026)
- Integrating Precision Nutrition with Pharmacological Therapies: Mechanisms, Clinical Outcomes, and Therapeutic Efficiency (Deadline: 30 September 2026)
- Management and Treatment of Cardiometabolic Disorders Across the Lifespan (Deadline: 5 October 2026)
- Melatonin Applications in Pharmaceutical Science (Deadline: 10 October 2026)
- New Advances in Antiarrhythmic Drugs (Deadline: 20 October 2026)
- Next-Generation Targeted Therapy: vNARs, VHH, and Peptides as Drug Carriers and Intracellular Neutralizing Agents (Deadline: 20 October 2026)
- Pharmacotherapy of Thromboembolism (Deadline: 25 October 2026)
- Epithelial Plasticity and Therapy Resistance in Cancer (Deadline: 25 October 2026)
- Pharmacovigilance Insights: Addressing Drug Misuse and Enhancing Drug Safety (Deadline: 25 October 2026)
- Novel Therapeutic Targets in the Cardiovascular Treatment Landscape (Deadline: 25 October 2026)
- Pharmacotherapy and Molecular Biomarkers of Metabolic Diseases (Deadline: 25 October 2026)
- Tumor Immunopharmacology, 2nd Edition (Deadline: 25 October 2026)
- Pharmacotherapy for Alzheimer’s Disease, 2nd Edition (Deadline: 25 October 2026)
- Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances, 2nd Edition (Deadline: 25 October 2026)
- Advances in Antiparasitic Drug Research: 2nd Edition (Deadline: 25 October 2026)
- Advancements in Cardiovascular and Antidiabetic Drug Therapy, 2nd Edition (Deadline: 27 October 2026)
- Kynurenine Pathway: A Novel Therapeutic Opportunity—2nd Edition (Deadline: 30 October 2026)
- NeuroImmunoEndocrinology (Deadline: 31 October 2026)
- Cholinergic Modulation, Anticholinergic Burden, and Neuroprotection: Mechanisms to Therapeutics (Deadline: 31 October 2026)
- Adjuvant Therapies for Cancer Treatment: 2nd Edition (Deadline: 31 October 2026)
- Precision Oncology: Targeting Molecular Subtypes in Cancer Therapy (Deadline: 31 October 2026)
- Molecular Insights and Clinical Implications in Geriatric Medicine and Drug Development (Deadline: 31 October 2026)
- Advances in Drug Hypersensitivity Research (Deadline: 31 October 2026)
- Optimizing Immunotherapeutic Strategies for Hematologic Malignancies (Deadline: 31 October 2026)
- Novel Cannabinoid Receptor Ligands: Discovery, Pharmacology, and Therapeutic Applications (Deadline: 31 October 2026)
- Drug Safety and Risk Management in Clinical Practice: 2nd Edition (Deadline: 31 October 2026)
- Animal Models in Pharmacological Research: Focusing on Oncology and Related Fields (Deadline: 31 October 2026)
- New Trends in the Treatment of Neuropsychiatric Disorders (Deadline: 10 November 2026)
- Applications of Stem Cells and Organoids in Disease Modeling, Drug Discovery and Clinical Evaluation (Deadline: 15 November 2026)
- Potential Therapeutic Targets for the Management of Diabetes Mellitus, Obesity and Cancer (Deadline: 25 November 2026)
- Pharmaceutical Approaches to Orofacial Pain and Chronic Pain Conditions (Deadline: 25 November 2026)
- Antimicrobial Therapies Affect the Microbial Ecosystems Within Our Body: The Urinary Microbiome and Urolithiasis (Deadline: 25 November 2026)
- Ischemic Stroke: Current and Emerging Treatment Strategies (Deadline: 25 November 2026)
- Curcumin: Current Status and Future Challenges in Drug Delivery and Advanced Formulations (Deadline: 25 November 2026)
- Hepatitis B and Delta Virus Infections: Mechanistic Insights and Clinical Drug Therapy (Deadline: 25 November 2026)
- Pharmacogenomics for Precision Medicine, 2nd Edition (Deadline: 25 November 2026)
- Pharmacovigilance in Drug Therapy and Adverse Reactions (Deadline: 25 November 2026)
- Pediatric Population Pharmacokinetics and Precision Dosing: From Therapeutic Drug Monitoring (TDM) to Dose Optimization (Deadline: 25 November 2026)
- Pharmacology of Respiratory Diseases (Deadline: 25 November 2026)
- Molecular Mechanisms and Treatment of Brain Cancer: Recent Advances and Future Trends: 2nd Edition (Deadline: 25 November 2026)
- The Application of Pharmacogenetics in Toxicity Prevention and Drug Effect Improvement—2nd Edition (Deadline: 27 November 2026)
- Comprehensive Strategies in Cancer Immunotherapy (Deadline: 30 November 2026)
- Drug Development and Emerging Pharmacotherapies in Stroke Management (Deadline: 30 November 2026)
- Pharmaceutical Targeting of Lipids in Metabolic and Neurological Disorders (Deadline: 30 November 2026)
- Pharmacological Therapy for Epilepsy (Deadline: 30 November 2026)
- Emerging Therapeutic Strategies and Resistance Mechanisms in Brain Tumors (Deadline: 30 November 2026)
- Pharmacology of Rare Diseases: Therapeutic Access for Orphan Medicines (Deadline: 1 December 2026)
- Development of Small Molecules as Immunomodulators and Adjuvants for Cancer Immunotherapy (Deadline: 20 December 2026)
- Novel Drug Compositions for Ischemic Stroke: Mechanisms and Clinical Applications (Deadline: 25 December 2026)
- Challenges in Discovering Innovations Related to Biofilms: Virulence, Spread, Control Strategies and Treatment (Deadline: 25 December 2026)
- Pharmacotherapy of Prostate Cancer (Deadline: 25 December 2026)
- Pharmacogenomics and Ethnic Diversity: Optimizing Drug Response Across Populations (Deadline: 25 December 2026)
- Recent Advances in Psychopharmacology: 2nd Edition (Deadline: 25 December 2026)
- Recent Advances in Animal Models of Neuropsychiatric Diseases (Deadline: 25 December 2026)
- Histamine Receptors: Ligand Design, Pharmacology, and Therapeutic Applications (Deadline: 30 December 2026)
- Novel Drug Candidates for the Treatment of Cardiac and Renal Diseases (Deadline: 31 December 2026)
- Pharmacotherapy of Macular Diseases (Deadline: 31 December 2026)
- Exploring Novel Therapies and Drug Efficacy for Inflammatory Bowel Disease (Deadline: 31 December 2026)
- Computational Predictions of Molecules with Potential Therapeutic Effects: 2nd Edition (Deadline: 31 December 2026)
- Research Advances in Targeted Therapy for Facial Skin Diseases (Deadline: 31 December 2026)
- Therapeutic Strategies for Co-Occurring Psychiatric and Substance Use Disorders (Deadline: 31 December 2026)
- Advances in Novel Drug Development Based on Drug Target Structure and Function (Deadline: 31 December 2026)
- Hematological Malignancies: From Drug Discovery Targets to Precision Medicine (Deadline: 31 December 2026)
- Advances in Pharmacological Therapies for Hematologic Malignancies (Deadline: 31 December 2026)
- Therapeutics for Substance Use Disorders (Deadline: 31 December 2026)
- Neurological Diseases: Investigating Molecular Mechanisms and Developing Novel Therapeutic Strategies (Deadline: 31 December 2026)
- Applications of EPR Spectroscopy in Pharmaceutical Research (Deadline: 31 December 2026)
- Advances in Cancer Treatment and Toxicity, 2nd Edition (Deadline: 31 December 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
